We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





Medlab Middle East 2023 Showcases Latest Laboratory Innovations and Technologies

By LabMedica International staff writers
Posted on 06 Feb 2023

The 22nd edition of Medlab Middle East Congress, is taking place live, in-person from 6-9 February 2023, in Dubai with a 100% increase in exhibitor numbers. More...

Co-hosted with Arab Health for the last two years, Medlab Middle East has more than 700 exhibitors displaying the latest laboratory innovations and technologies to an audience of over 20,000 visitors representing more than 180 countries throughout the show's four days.

The 2023 edition of Medlab Middle East, the MENA region’s largest medical laboratory exhibition and congress organized by Informa Markets (London, UK), has returned as a standalone event following unprecedented demand from exhibitors and visitors to attend the show. This year’s exhibition theme ‘paving the way for technological advancements and sustainability in laboratory medicine’ underscores the rate at which laboratory technology has advanced in recent years. In addition to a showcase of products ranging from high-performance solutions and advanced technology to affordable alternatives, Medlab Middle East is revealing a range of new and returning features.

Making its debut at the show is Labpreneur, which gathers the most exciting and promising medical laboratory start-ups from across the world as they actively address the unmet challenges and revolutionize the medical lab industry. The competition features the top 10 innovative early and middle-stage start-ups from across the world, pitching their ground-breaking ideas and battling on stage in front of an esteemed panel of judges, which includes investors, industry experts, and entrepreneurs. Sustainability is also in focus and is being highlighted during the Lab Sustainability Awards. The awards encourage action on various sustainable laboratory areas and link to one of the 17 Sustainable Development Goals (SDGs), part of the 2030 Agenda for Sustainable Development with the winners announced during the last session of the “Sustainability in the lab” conference.

Medlab Middle East is also hosting the LabQ, an inter-college quiz competition focusing on the area of pathology and laboratory medicine for senior graduating college and university students majoring in medical laboratory sciences in the UAE. In addition, the scientific poster competition returning in 2023 is dedicated to helping grow the medical laboratory industry by providing a platform to gain recognition and be published. The winner gets the opportunity to speak at Medlab Asia 2023, which takes place in Bangkok, with flights and accommodation included.

The Medlab Middle East Congress also returns this year, providing education and solutions to advance laboratory skills and improve laboratory functions to over 5,000 conference delegates. With 13 conferences, the Congress is the largest CME-accredited multi-track medical laboratory congress globally, featuring 130+ local and international speakers. This year's conference program includes eight core lab conference tracks​, with a further four new additions addressing Point of Care Testing (POCT), Tech Advances and Clinical Impact, New Trends In Laboratory Medicine, Quality Management in the Lab, and Sustainability in the Lab.

“We have seen the demand for clinical laboratory services increase significantly in the last two years. As such, we’ve witnessed a surge in demand from visitors and exhibitors. COVID-19 undoubtedly put increased focus on the laboratory market. Subsequently, we have seen a wealth of new technology and innovation being adopted, which is driving automation and collaboration with the lab and critical external stakeholders,” said Tom Coleman, Exhibition Director for Inform Markets. “More generally, we have seen factors such as the rising prevalence of chronic illnesses and the resulting need for early diagnostic testing contributing to the growth in the size of the lab market. The speed of technological advances in raising productivity and cost savings will also be a key factor in driving the industry’s growth.”

Related Links:
Informa Markets 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Drug Testing Assays
Atellica DT 250 Analyzer
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: LVOne uses blood-based biomarkers to detect stroke and identify large vessel occlusion before hospital arrival, providing objective results earlier than traditional assessments. (Photo courtesy of UpFront Diagnostics)

First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage

Rapid stroke identification before hospital arrival is critical because treatment efficacy declines with every minute of delay. However, definitive assessment typically requires hospital-based imaging,... Read more

Molecular Diagnostics

view channel
Image: MPNST is a cancer of the connective tissue surrounding peripheral nerves, with NF1 being a key risk factor (Image Credit: Nephron/Wikimedia Commons (CC BY-SA 3.0)

Liquid Biopsy Shows Promise for Detecting and Monitoring Malignant Nerve Sheath Tumors

Malignant peripheral nerve sheath tumor (MPNST) is one of the most serious cancers affecting people with neurofibromatosis type 1 (NF1), yet timely recognition remains difficult. Clinicians often struggle... Read more

Microbiology

view channel
Image: Ebola remains a rapidly evolving public health threat with high mortality, underscoring the need for timely diagnosis and decentralized testing closer to patients (Image Credit: Adobe Stock)

Collaboration Targets Blood-Based Ebola Detection Outside Central Laboratories

Co-Diagnostics, Inc. (Salt Lake City, UT, USA) and ReadyGo Diagnostics Ltd. (Bath, UK) have initiated a collaboration to evaluate ReadyGo’s GoCollect with the Co-Dx PCR platform for blood-based molecular... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.